MARKET

SPHRF

SPHRF

Starpharma Holdings Ltd
OTCQX
0.350
NaN%
Closed 09:30 09/28 EDT
OPEN
--
PREV CLOSE
0.350
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.350
52 WEEK LOW
0.240
MARKET CAP
166.97M
P/E (TTM)
-29.1667
1D
5D
1M
3M
1Y
5Y
1D
UBS Group AG Withdraws as Substantial Shareholder in Starpharma
TipRanks · 3d ago
UBS exits substantial holder position in Starpharma
TipRanks · 09/15 08:28
Starpharma sets 2026 AGM date and flags board nomination deadline
TipRanks · 09/15 06:02
UBS Group Ceases to Be Substantial Shareholder in Starpharma
TipRanks · 08/31 09:24
Starpharma Highlights Patient-Focused Dendrimer Strategy in Annual Report
TipRanks · 08/26 01:04
Starpharma Boosts Revenue on Genentech Deal While Deepening R&D Spend
TipRanks · 08/26 00:17
UBS Group AG Drops Below Substantial Holding in Starpharma
TipRanks · 08/19 07:46
Starpharma Director Increases Stake Through Entitlement Offer
TipRanks · 08/13 11:12
More
About SPHRF
Starpharma Holdings Limited is an Australia-based biotechnology company specializing in advancing dendrimer technology. The Company's principal activities are focused on the research, development and commercialization of dendrimer technology for pharmaceutical and healthcare applications. The Company's portfolio of dendrimer-based products includes three clinical-stage dendrimer enhanced product (DEP) assets, preclinical radiopharmaceutical assets, research collaborations, and three commercially marketed over the counter (OTC) products. Its clinical-stage assets, DEP SN38, DEP cabazitaxel, and DEP docetaxel, are dendrimer-based chemotherapeutic drugs. Additionally, the Company has a preclinical pipeline of DEP radiopharmaceuticals in development. It also manufactures and sells SPL7013 (astodrimer sodium) proprietary products: VivaGel BV, Viraleze nasal spray, and VivaGel condom. The Company has applied its DEP technology to the innovative area of antibody-drug conjugates.

Webull offers Starpharma Holdings Ltd stock information, including OTCQX: SPHRF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPHRF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SPHRF stock methods without spending real money on the virtual paper trading platform.